Pharma Continues To Sit In Back Seat As Tobacco, Food Priorities Take Center Stage At FDA

20 Oct 2023

New FDA Deputy Commissioner for Policy, Legislation and International Affairs Kimberlee Trzeciak has non-medical product work on the top of her agenda, highlighting the shift in attention that has been a mainstay of FDA commissioner Robert Califf's tenure.

back seat of a car — Drug issues could get some attention as part of a broader agencywide focus on supply chain resilience, but are mostly taking a back seat to other FDA public health initiatives. • Source: Shutterstock

Pharma Continues To Sit In Back Seat As Tobacco, Food Priorities Take Center Stage At FDA

More from US FDA

More from Agency Leadership